Clinical Trial

Patients with Moderate to Severe Plaque Psoriasis Registry

Study Description

A Registry of Patients With Moderate to Severe Plaque Psoriasis

The main purpose of the current study will be to provide real - world evidence regarding the safety and effectiveness of secukinumab in the management of patients with moderate to severe chronic plaque psoriasis.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Secikinumab

Additional Information

Official Study Title

A Registry of Patients With Moderate to Severe Chronic Plaque Psoriasis in Canada and Latin AmErica (LACan)

Clinical Trial ID

NCT02786186

ParticipAid ID

QeZGQa